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Therapeutic Revolutions presents the reader a collection of essays that seek to re-evaluate the 
explanatory power of ‘narratives of revolutionary change in biomedical therapeutics’ (p. 2). 
In this volume, editors Jeremy A. Greene, Flurin Condrau, and Elizabeth Siegel Watkins 
assemble a thought-provoking debate on the widely known notion of therapeutic revolution, 
discussed since Charles Rosenberg initiated the conversation in 1977. The argument is driven 
by a dialogue both across and within the contributors’ fields of the history of medicine, 
medical anthropology, and social studies of medicine. Ultimately, the question they pose is: 
‘What is revolutionary about therapeutics?’ (p. 2). Together, these chapters form a 
convincing argument, of which only a few points will be highlighted here. 
And so, the story goes: ‘back then we had few effective remedies, now we have more (and 
more powerful) tools to fight disease’ (p. 1, emphasis added). Narratives of medical 
modernity generally assume that dramatic social changes were driven by the introduction of 
pharmaceuticals into the practice of biomedicine. Through the authors’ descriptions and 
analyses of therapeutic transformations in relation to the use of antibiotics, contraceptives, 
psychiatric drugs, cardiovascular drugs, and chemotherapies, the authors collectively 
challenge the linearity of this historical narrative, which might often function to obscure the 
actual sociocultural and political dimensions of social change (p. 3).  
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A therapeutic revolution, the editors argue, is a particular actor’s narrative of the past, not an 
objective event in itself. Claims to revolution often differentiate a modern, elegant, and 
scientific future from a superstitious, irrational, and ignorant past. But who are the heroes of 
these revolutions? Who tells these revolutionary tales? To whom are they delivered? Some 
stakeholders may have had something else at stake than others. Almost by travelling in time, 
the editors of and contributors to this volume show us how thinking about the tales of 
revolutions also requires asking about timeframes, continuity, and change, and how 
‘medicine changes, for whom, where, and with what consequences’ (p. 13). 
The editors’ ambition to challenge the linearity of the tale of therapeutic revolution becomes 
evident in the first chapter. Scott H. Podolsky and Anne K. Lie provide an outstanding 
starting point for this volume’s argument, as they discuss the use of historical futures in the 
context of the so-called antibiotic revolution. Past futures often tend to be forgotten, they 
argue, but such ‘expectations of the future tell us a great deal about both the scientific and 
cultural contexts of their origins’ (p. 20). The antibiotic revolution is a valuable example of 
how evidence, policy, the imagined future – be it utopian or dystopian – and our 
expectations of it may play intricate roles in shaping antibiotic therapies, as well as how they 
are developed, administered, and used. Condrau and Janina Kehr go further in their chapter 
on antibiotic treatments and the ‘return’ of tuberculosis, as they consider the recurrence of 
antibiotic revolutions, ‘in which tropes of emergency and threat, urgency and fear, hope and 
progress have been repeatedly employed, albeit by shifting actors’ (p. 143). There is not just 
one revolution, but many, this book shows, continually being employed in different contexts. 
Elizabeth Siegel Watkins and Nicolas Henckes go on to consider the revolutionary aspects 
of the contraceptive pill and psychotropic drugs. These two drugs, together with antibiotics 
and in the name of a therapeutic revolution, became known as the wonder drugs of the 
twentieth century. Their chapters show how these medicines may have paved the way for the 
normalisation of a routine practice of pharmaceutical spending for millions of people around 
the world, whilst accounting for a highly profitable market of daily drug consumption.   
Most descriptions of the therapeutic revolution include a cumulative history of 
pharmaceutical invention, where more and more potent drugs have replaced less effective 
previous ones. While these three pharmaceutical drugs – antibiotics, contraceptives, and 
psychotropics – have been the central figures of therapeutic revolution rhetoric, the list of 
other pharmaceuticals developed during the second half of the twentieth century is long, 
including cardiovascular drugs, sedatives, and analgesics, among others. Nils Kessel and 
Christian Bonah’s archival market analysis shows how different drugs coexist, despite being 
more or less clinically effective. This coexistence of drug treatments and the notion of 
efficacy are further discussed by Julie Livingston, in a remarkable analysis of Botswana’s 
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ambiguous provision of care with chemotherapy and antiretroviral drugs during the early 
2000s.  
One of the volume’s embedded arguments – that some actors may have benefited more than 
others from this revolution – follows on from Jeremy Greene’s emphasis that not all people 
have had equal access to the powerful new therapies becoming available in the 
pharmaceutical market over the past decades, a market mostly led by North American 
private industry. Geographic boundaries and pharmaceutical access in the developing world, 
but also in European or North American contexts, have been a frequent topic in 
international public health circles, along with debates on transference, patents, and 
commercial tracks that could resolve these geographic limitations. Continuing with this 
topic, Kristin Peterson offers an ethnographic case study of the complexities of drug-market 
making in Nigeria. 
Some of the final contributions to this volume are more theoretical. Paul Farmer and 
colleagues revisit Thomas McKeown’s theory on global mortality declines, and inquire about 
the role of biomedicine in improving and delivering health. David S. Jones presents a 
discussion of the metaphors of revolution and evolution, and reflects on the consequences 
of their uses in medicine and history. For those familiar with biomedical science, like myself, 
Jones’s adaptation of evolutionary biology concepts, such as niche, fitness, and the Red 
Queen hypothesis, to historical analysis might come across as controversial, although as he 
notes, ‘used carefully. . . the language of evolution can be a valuable tool for historians to 
think with’ (p. 273, emphasis added). Indeed, such language would need to be borrowed with 
care. 
A broad audience of readers will take pleasure in this volume, and especially in how the 
cross-talk among anthropology, history of medicine, and social studies of science engenders 
compelling questions, most yet to be answered. Due to the editors’ choice to have Charles 
Rosenberg’s brief revision of his own work on the idea of therapeutic revolution as the 
book’s closing, the book does not offer a conclusive argument on what is actually 
revolutionary about pharmaceutical molecules, leaving many questions open and making the 
experience of a journey through such different drug histories and disciplines slightly 
disorienting.   
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